Post-Epidemic Era, Genome Sequencing Industry Development Trend Analysis Report 2023

Report Code : ARS2753554
Published On: Jul, 2023
Category : Healthcare & Pharma
Pages : 100

The global Genome Sequencing market size in 2022 is 16716.6 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 16.20% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Genome Sequencing market include Abbott (U.S.), BioMérieux (France), B.D. (U.S.), Danaher (U.S., and Thermo Fisher Scientific Inc., (U.S.). The share of the top 3 players in the Genome Sequencing market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Genome Sequencing market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. PCR accounted for XX% of Genome Sequencing market in 2022. Sequencing share of XX%.
Research Centers accounted for XX% of the Genome Sequencing market in 2022. Academic and Government Institutes accounts for XX%.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Genome Sequencing Market dynamics, structure by identifying and analyzing the market segments and project the global market size.
In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.
Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Nordic
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Player list
Abbott (U.S.)
BioMérieux (France)
B.D. (U.S.)
Danaher (U.S.
Thermo Fisher Scientific Inc., (U.S.)
Siemens (Germany)
Agilent Technologies, Inc, (U.S.)
Merck KGaA (Germany)
Illumina Inc. (U.S.)
QIAGEN (Germany)
Bio-Rad Laboratories, Inc. (U.S.)
Eurofins Scientific (Luxembourg)
Danaher (U.S.)
Oxford Nanopore Technologies plc (U.K.).
F. Hoffmann-La Roche Ltd (Switzerland)
BGI (U.S.), General Electric (U.S.)
LI-COR, Inc (U.S.).
Siemens (U.S.)
PerkinElmer, Inc. (U.S.).
Macrogen, Inc (South Korea)
BIONEER CORPORATION (South Korea)
Types list
PCR
Sequencing
Microarray
Nucleic Acid Extraction
Purification
Others
Application list
Research Centers
Academic and Government Institutes
Hospitals & Clinics
Pharmaceutical and Biotechnology Companies
Others
With tables and figures helping analyze worldwide Post Epidemic Era Genome Sequencing market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Content

1 Genome Sequencing Market Introduction and Overview
1.1 Genome Sequencing Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions

2 Players Profiles
2.1 Abbott (U.S.)
2.1.1 Abbott (U.S.) Company Profile
2.1.2 Genome Sequencing Product Overview
2.1.3 Abbott (U.S.) Genome Sequencing Market Performance (2018-2023)
2.1.4 Abbott (U.S.) Business Overview
2.2 BioMérieux (France)
2.2.1 BioMérieux (France) Company Profile
2.2.2 Genome Sequencing Product Overview
2.2.3 BioMérieux (France) Genome Sequencing Market Performance (2018-2023)
2.2.4 BioMérieux (France) Business Overview
2.3 B.D. (U.S.)
2.3.1 B.D. (U.S.) Company Profile
2.3.2 Genome Sequencing Product Overview
2.3.3 B.D. (U.S.) Genome Sequencing Market Performance (2018-2023)
2.3.4 B.D. (U.S.) Business Overview
2.4 Danaher (U.S.
2.4.1 Danaher (U.S. Company Profile
2.4.2 Genome Sequencing Product Overview
2.4.3 Danaher (U.S. Genome Sequencing Market Performance (2018-2023)
2.4.4 Danaher (U.S. Business Overview
2.5 Thermo Fisher Scientific Inc., (U.S.)
2.5.1 Thermo Fisher Scientific Inc., (U.S.) Company Profile
2.5.2 Genome Sequencing Product Overview
2.5.3 Thermo Fisher Scientific Inc., (U.S.) Genome Sequencing Market Performance (2018-2023)
2.5.4 Thermo Fisher Scientific Inc., (U.S.) Business Overview
2.6 Siemens (Germany)
2.6.1 Siemens (Germany) Company Profile
2.6.2 Genome Sequencing Product Overview
2.6.3 Siemens (Germany) Genome Sequencing Market Performance (2018-2023)
2.6.4 Siemens (Germany) Business Overview
2.7 Agilent Technologies, Inc, (U.S.)
2.7.1 Agilent Technologies, Inc, (U.S.) Company Profile
2.7.2 Genome Sequencing Product Overview
2.7.3 Agilent Technologies, Inc, (U.S.) Genome Sequencing Market Performance (2018-2023)
2.7.4 Agilent Technologies, Inc, (U.S.) Business Overview
2.8 Merck KGaA (Germany)
2.8.1 Merck KGaA (Germany) Company Profile
2.8.2 Genome Sequencing Product Overview
2.8.3 Merck KGaA (Germany) Genome Sequencing Market Performance (2018-2023)
2.8.4 Merck KGaA (Germany) Business Overview
2.9 Illumina Inc. (U.S.)
2.9.1 Illumina Inc. (U.S.) Company Profile
2.9.2 Genome Sequencing Product Overview
2.9.3 Illumina Inc. (U.S.) Genome Sequencing Market Performance (2018-2023)
2.9.4 Illumina Inc. (U.S.) Business Overview
2.10 QIAGEN (Germany)
2.10.1 QIAGEN (Germany) Company Profile
2.10.2 Genome Sequencing Product Overview
2.10.3 QIAGEN (Germany) Genome Sequencing Market Performance (2018-2023)
2.10.4 QIAGEN (Germany) Business Overview
2.11 Bio-Rad Laboratories, Inc. (U.S.)
2.11.1 Bio-Rad Laboratories, Inc. (U.S.) Company Profile
2.11.2 Genome Sequencing Product Overview
2.11.3 Bio-Rad Laboratories, Inc. (U.S.) Genome Sequencing Market Performance (2018-2023)
2.11.4 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
2.12 Eurofins Scientific (Luxembourg)
2.12.1 Eurofins Scientific (Luxembourg) Company Profile
2.12.2 Genome Sequencing Product Overview
2.12.3 Eurofins Scientific (Luxembourg) Genome Sequencing Market Performance (2018-2023)
2.12.4 Eurofins Scientific (Luxembourg) Business Overview
2.13 Danaher (U.S.)
2.13.1 Danaher (U.S.) Company Profile
2.13.2 Genome Sequencing Product Overview
2.13.3 Danaher (U.S.) Genome Sequencing Market Performance (2018-2023)
2.13.4 Danaher (U.S.) Business Overview
2.14 Oxford Nanopore Technologies plc (U.K.).
2.14.1 Oxford Nanopore Technologies plc (U.K.). Company Profile
2.14.2 Genome Sequencing Product Overview
2.14.3 Oxford Nanopore Technologies plc (U.K.). Genome Sequencing Market Performance (2018-2023)
2.14.4 Oxford Nanopore Technologies plc (U.K.). Business Overview
2.15 F. Hoffmann-La Roche Ltd (Switzerland)
2.15.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile
2.15.2 Genome Sequencing Product Overview
2.15.3 F. Hoffmann-La Roche Ltd (Switzerland) Genome Sequencing Market Performance (2018-2023)
2.15.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
2.16 BGI (U.S.), General Electric (U.S.)
2.16.1 BGI (U.S.), General Electric (U.S.) Company Profile
2.16.2 Genome Sequencing Product Overview
2.16.3 BGI (U.S.), General Electric (U.S.) Genome Sequencing Market Performance (2018-2023)
2.16.4 BGI (U.S.), General Electric (U.S.) Business Overview
2.17 LI-COR, Inc (U.S.).
2.17.1 LI-COR, Inc (U.S.). Company Profile
2.17.2 Genome Sequencing Product Overview
2.17.3 LI-COR, Inc (U.S.). Genome Sequencing Market Performance (2018-2023)
2.17.4 LI-COR, Inc (U.S.). Business Overview
2.18 Siemens (U.S.)
2.18.1 Siemens (U.S.) Company Profile
2.18.2 Genome Sequencing Product Overview
2.18.3 Siemens (U.S.) Genome Sequencing Market Performance (2018-2023)
2.18.4 Siemens (U.S.) Business Overview
2.19 PerkinElmer, Inc. (U.S.).
2.19.1 PerkinElmer, Inc. (U.S.). Company Profile
2.19.2 Genome Sequencing Product Overview
2.19.3 PerkinElmer, Inc. (U.S.). Genome Sequencing Market Performance (2018-2023)
2.19.4 PerkinElmer, Inc. (U.S.). Business Overview
2.20 Macrogen, Inc (South Korea)
2.20.1 Macrogen, Inc (South Korea) Company Profile
2.20.2 Genome Sequencing Product Overview
2.20.3 Macrogen, Inc (South Korea) Genome Sequencing Market Performance (2018-2023)
2.20.4 Macrogen, Inc (South Korea) Business Overview
2.21 BIONEER CORPORATION (South Korea)
2.21.1 BIONEER CORPORATION (South Korea) Company Profile
2.21.2 Genome Sequencing Product Overview
2.21.3 BIONEER CORPORATION (South Korea) Genome Sequencing Market Performance (2018-2023)
2.21.4 BIONEER CORPORATION (South Korea) Business Overview

3 Global Genome Sequencing Historical and Forecast Market Analysis by Type
3.1 Global Genome Sequencing Revenue and Market Share by Type
3.2 Global Genome Sequencing Revenue Market Forecast by Type (2023-2029)

4 Global Genome Sequencing Historical and Forecast Market Analysis by Application
4.1 Global Genome Sequencing Revenue Market Share by Application (2018-2023)
4.2 Genome Sequencing Revenue Market Forecast by Application (2023-2029)

5 Global Market Growth Trends Analysis
5.1 Global Genome Sequencing Market Size & Forecast (2018-2029)
5.2 Genome Sequencing Growth Trends Analysis by Regions
5.2.1 Genome Sequencing Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Genome Sequencing Historic Market Size by Regions (2018-2023)
5.2.3 Genome Sequencing Forecasted Market Size by Regions (2023-2029)
5.2.4 North America Genome Sequencing Market Size & Forecast (2018-2029)
5.2.5 Europe Genome Sequencing Market Size & Forecast (2018-2029)
5.2.6 China Genome Sequencing Market Size & Forecast (2018-2029)
5.2.7 Asia-Pacific (Excluding China) Genome Sequencing Market Size & Forecast (2018-2029)
5.2.8 Latin America Genome Sequencing Market Size & Forecast (2018-2029)
5.2.9 Middle East & Africa Genome Sequencing Market Size & Forecast (2018-2029)

6 North America
6.1 North America Genome Sequencing Revenue by Players
6.2 North America Genome Sequencing Revenue by Types
6.3 North America Genome Sequencing Revenue by Applications
6.4 North America Genome Sequencing Market by Countries
6.4.1 North America Genome Sequencing Revenue by Countries (2018-2029)
6.5 United States
6.6 Canada

7 China
7.1 China Genome Sequencing Revenue by Players
7.2 China Genome Sequencing Revenue by Types
7.3 China Genome Sequencing Revenue by Applications
7.4 China

8 Asia Pacific (Excluding China)
8.1 Asia Pacific Genome Sequencing Revenue by Players
8.2 Asia Pacific Genome Sequencing Revenue by Types
8.3 Asia Pacific Genome Sequencing Revenue by Applications
8.4 Asia Pacific Genome Sequencing Market by Countries
8.4.1 Asia Pacific Genome Sequencing Revenue by Countries (2018-2029)
8.5 Japan
8.6 Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

9 Europe
9.1 Europe Genome Sequencing Revenue by Players
9.2 Europe Genome Sequencing Revenue by Types
9.3 Europe Genome Sequencing Revenue by Applications
9.4 Europe Genome Sequencing Market by Countries
9.4.1 Europe Genome Sequencing Revenue by Countries (2018-2029)
9.5 Germany
9.6 France
9.7 UK
9.8 Italy
9.9 Russia
9.10 Nordic

10 Latin America
10.1 Latin America Genome Sequencing Revenue by Players
10.2 Latin America Genome Sequencing Revenue by Types
10.3 Latin America Genome Sequencing Revenue by Applications
10.4 Latin America Genome Sequencing Market by Countries
10.4.1 Latin America Genome Sequencing Revenue by Countries (2018-2029)
10.5 Brazil
10.6 Argentina
10.7 Mexico

11 Middle East & Africa
11.1 Middle East & Africa Genome Sequencing Revenue by Players
11.2 Middle East & Africa Genome Sequencing Revenue by Types
11.3 Middle East & Africa Genome Sequencing Revenue by Applications
11.4 Middle East & Africa Genome Sequencing Market by Countries
11.4.1 Middle East & Africa Genome Sequencing Revenue by Countries (2018-2029)
11.5 Egypt
11.6 South Africa
11.7 Israel
11.8 Turkey
11.9 GCC Countries

12 Genome Sequencing Industry Dynamic Analysis
12.1 Genome Sequencing Market Trends Analysis
12.2 Genome Sequencing Market Drivers Analysis
12.3 Genome Sequencing Market Challenges Analysis
12.4 Genome Sequencing Market Restraints Analysis
12.5 Genome Sequencing Industry Mergers & Acquisitions
12.6 Genome Sequencing Industry New Entrants and Expansion Plans

13 Research Findings and Conclusion
The Post Epidemic Era Genome Sequencing Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

Report Objectives / Segmentation Covered :

By Companies / players:
By Regions:
By Type:
By Application:

Frequently asked questions(FAQ's):

Is the Post Epidemic Era Genome Sequencing Market shifting its focus from growth to value?

Recognize the areas along the Post Epidemic Era Genome Sequencing Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.

What are the major applications of the Post Epidemic Era Genome Sequencing Market?

Depending upon the type of applications, the Post Epidemic Era Genome Sequencing Market has been segmented into and other applications.

What is the forecasted growth rate of the Post Epidemic Era Genome Sequencing Market?

The Post Epidemic Era Genome Sequencing Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.

Where does the Post Epidemic Era Genome Sequencing Industry stands in terms of scaling end-use implementations?

According to the Post Epidemic Era Genome Sequencing Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.

Who should consider the Post Epidemic Era Genome Sequencing Market study?

The Post Epidemic Era Genome Sequencing Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.